An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Myomo, Inc. Announces Participation in Three September Investment Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Myomo, Inc. (NYSE American:MYO), a company specializing in wearable medical robotics for neurological disorders and upper-limb paralysis, announced participation in three investment conferences in September 2021. These include the Colliers Institutional Investor Conference on September 9, the H.C. Wainwright Global Investment Conference from September 13-15, and the Oppenheimer Fall Healthcare Summit from September 20-23. Myomo's MyoPro device is the only one that restores arm function using the patient's own EMG signals, enabling independence for users.
Positive
Participation in three key investment conferences, potentially increasing visibility and investor interest.
Innovative MyoPro product provides unique functionality by using EMG signals, differentiating Myomo in the market.
Negative
None.
BOSTON--(BUSINESS WIRE)--
Myomo, Inc. (NYSE American:MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, Myomo’s chairman and chief executive officer, and David Henry, Myomo’s chief financial officer, will participate in three investment conferences in September. They are:
2021 Colliers Institutional Investor Conference, which will be held virtually, on Thursday, September 9, 2021. This conference’s format is 1x1 meetings with institutional investors.
H.C. Wainwright 23rd Annual Global Investment Conference, which will be held virtually from September 13-15, 2021. Investors interested in participating should contact H.C. Wainwright directly or register here.
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, which will be held virtually September 20-23, 2021. Management’s presentation may be accessed beginning at 12:25 p.m. ET on September 21 at this link, which will also be available for a period of time in the investor relations section of the Company’s website.
About Myomo
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Boston, Massachusetts, with sales and clinical professionals across the U.S. and representatives internationally. For more information, please visit www.myomo.com.
Investor Relations:
Kim Sutton Golodetz LHA Investor Relations
kgolodetz@lhai.com
212-838-3777
Source: Myomo, Inc.
FAQ
What is Myomo, Inc. (MYO)?
Myomo, Inc. is a wearable medical robotics company focused on improving arm and hand function for individuals suffering from neurological disorders and upper-limb paralysis.
What conferences is Myomo participating in September 2021?
Myomo is participating in the Colliers Institutional Investor Conference on September 9, H.C. Wainwright Global Investment Conference from September 13-15, and Oppenheimer Fall Healthcare Summit from September 20-23.
What is the MyoPro device offered by Myomo?
The MyoPro device is a powered upper limb orthosis designed to assist individuals with weakened or paralyzed arms. It uses the patient's own EMG signals to restore functionality.
How does MyoPro benefit its users?
MyoPro helps users perform daily activities, enhances independence, allows many to return to work, and may reduce care costs.
